Valeant Pharmaceuticals said that effective December 31, 2008; the company completed its acquisition of Dow Pharmaceutical Sciences, a privately held dermatology company that specializes in the development of topical products on a proprietary basis, as well as for pharmaceutical and biotechnology companies.
Valeant completes acquisition of Dow Pharma
2014-10-08T16:47:19+00:00January 4th, 2009|